Fundraise

Mosaic Biosciences files for undisclosed equity raise in Boulder

What's the deal? Mosaic Biosciences, a Boulder, Colorado-based health care company, filed a Form D with the Securities and Exchange Commission on November 19, 2026, signalling an exempt securities offering. The filing lists the company as incorporated in Delaware more than five years ago.

Who's involved? The notice names a deep bench of executives and directors, including Eric Furfine and Jean-Pierre Wery, who are listed as both executive officers and directors. Deval Lashkari was elected a director in connection with the closing of the offering.

Why it matters: A Form D is the paperwork companies file when raising capital through a private placement exempt from full SEC registration. The filing confirms the round has closed, even though the amount was not disclosed in the available detail.

The signal: Private biotech raises continue to flow through Form D filings, which often surface before any formal announcement. For Mosaic Biosciences, the paperwork marks a fresh round of fundraising from a company that has been operating for over five years.

Read more: streetinsider.com

Image credit: Generated with Gemini

More top stories